SIL Stock UPDATES G-X Silver Miners ETF (SIL) 12.75 09/07/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
G-X Silver Miners ETF (SIL) 12.75 $SIL

Uptrend Call Working As Global X Silver Miners ETF Stock Rises 11.6% (SIL)
Comtex SmarTrend(R) - Mon Aug 18, 4:52PM CDT
SmarTrend identified an Uptrend for Global X Silver Miners ETF (NYSE:SIL) on June 13th, 2014 at $12.63. In approximately 2 months, Global X Silver Miners ETF has returned 11.56% as of today's recent price of $14.09.

Global X Silver Miners ETF Up 14.3% Since SmarTrend Uptrend Call (SIL)
Comtex SmarTrend(R) - Mon Aug 11, 12:40PM CDT
SmarTrend identified an Uptrend for Global X Silver Miners ETF (NYSE:SIL) on June 13th, 2014 at $12.63. In approximately 2 months, Global X Silver Miners ETF has returned 14.32% as of today's recent price of $14.44.

Global X Silver Miners ETF Has Returned 10.1% Since SmarTrend Recommendation (SIL)
Comtex SmarTrend(R) - Mon Aug 04, 9:58AM CDT
SmarTrend identified an Uptrend for Global X Silver Miners ETF (NYSE:SIL) on June 13th, 2014 at $12.63. In approximately 2 months, Global X Silver Miners ETF has returned 10.13% as of today's recent price of $13.91.

Shares of SIL Up 12.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Jul 28, 9:26AM CDT
SmarTrend identified an Uptrend for Global X Silver Miners ETF (NYSE:SIL) on June 13th, 2014 at $12.63. In approximately 2 month, Global X Silver Miners ETF has returned 12.03% as of today's recent price of $14.15.

12.0% Return Seen to Date on SmarTrend Global X Silver Miners ETF Call (SIL)
Comtex SmarTrend(R) - Fri Jul 18, 9:23AM CDT
SmarTrend identified an Uptrend for Global X Silver Miners ETF (NYSE:SIL) on June 13th, 2014 at $12.63. In approximately 1 month, Global X Silver Miners ETF has returned 12.03% as of today's recent price of $14.15.

Top ETF Picks for Q2 Earnings Season - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Jul 15, 1:00PM CDT
It might be a great idea to focus in on those ETFs with large allocations to stocks that have a high chance of beating earnings estimate in their upcoming release.

Why Silver Could Outshine Gold
at The Street - Fri Mar 21, 8:39AM CDT
After suffering a long downturn, silver looks relatively cheap.

Can the Run Continue for Silver Mining ETFs? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 9:00AM CST
After their big run, where do silver mining ETFs go from here?

With a Quiet Dow, All Eyes Are on Gold
Dan Caplinger, The Motley Fool - Motley Fool - Tue Feb 18, 3:32PM CST
Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing thesis. Tuesday's post-holiday  Dow Jones Industrials  trading...

The Real Winner from the Precious Metal ETF Rally - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Wed Feb 12, 5:06AM CST
While gold has been seeing strength, silver miners have really been leading the charts as of late.

PureFunds to Fold 2 Mining ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Jan 22, 7:09AM CST
PureFunds will be closing down two ETFs which failed to garner a meaningful level of assets.

Will Gold and Silver Continue to Fall in 2014?
James Catlin, The Motley Fool - Motley Fool - Mon Dec 30, 12:16PM CST
It's no secret that the inflation some predicted at the hands of the Fed's liquidity injection plan never materialized. The run that gold saw amid these fears therefore became unsubstantiated. Now the decline has started and will continue save some...




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lumexa Imaging's Investor Conference Push: Any Real Substance?

Updated Category News Views 132

Lumexa Imaging just dropped a line on Feb 17, 2026, about their upcoming investor conference gigs. Sure, they're strutting into multiple events—Raymond James in Orlando, Leerink Partners in Miami, and Barclays back-to-back days after that. But here’s the kicker: are these talks really worth the buzz? In a space where outpatient imaging claims to be kingpin, you’ve...

Continue Reading
Current Landscape of US Stock Futures Amid Rate Cuts

Updated Category News Views 173

Insights on the Current Stability of U.S. Stock Futures During Asian trading hours, U.S. stock index futures have held steady. Investors are hoping for interest rate cuts as the Federal Reserve's next meeting approaches. This meeting is expected to reveal a significant easing cycle that many in the market are eagerly anticipating. Even with strong reports on consumer and...

Continue Reading
Wispr Flow Revolutionizes Voice Dictation Across Platforms

Updated Category News Views 469

Wispr Flow Expands Its Reach in Voice Dictation Technology In a world where speed and efficiency are paramount, Wispr, known as The Voice Interface Company, is revolutionizing the way we interact with technology. With the recent launch of Wispr Flow for Windows, this innovative voice productivity tool is now accessible to users across both Mac and Windows platforms,...

Continue Reading
MintMiner: Your Ultimate Gateway to Cloud Mining Success

Updated Category News Views 197

Unlocking the Future of Cloud Mining with MintMiner In today's uncertain financial landscape, MintMiner presents an innovative solution for anyone looking to tap into the world of digital assets. As global financial systems face challenges, MintMiner offers a unique platform that makes cloud mining accessible, straightforward, and profitable. Understanding Cloud Mining...

Continue Reading
GT Biopharma's Strategic Move: Withdrawal of S-1 Registration

Updated Category News Views 100

GT Biopharma's Strategic Withdrawal of Form S-1 Registration GT Biopharma, Inc. (NASDAQ: GTBP) recently made headlines with its request for withdrawal of a Form S-1 registration statement. This decision marks a crucial moment for the company, based in San Francisco, known for its innovative approach in the immuno-oncology sector. GT Biopharma focuses on the development of...

Continue Reading